| Literature DB >> 31309920 |
W Katherine Yih1, Martin Kulldorff2, David J Friedman3, Jessica H Leibler4, Juan José Amador5, Damaris López-Pilarte5, Renee L Galloway6, Oriana Ramírez-Rubio5, Alejandro Riefkohl5, Daniel R Brooks5.
Abstract
A chronic kidney disease of unknown etiology (CKDu) has been killing workers in Central America. Occupational heat stress is thought to play an important role. Leptospirosis and hantavirus have been suggested as additional possible risk factors. In a case-control study in a Nicaraguan mining community, a structured survey was administered to adults, and biological measurements and specimens were taken. Serum was analyzed for antibodies to Leptospira and hantavirus. Before statistical analysis, a board-certified nephrologist determined final case and control status based on serum creatinine and other laboratory values. Multivariable analysis was by logistic regression. In sensitivity analyses, cases were restricted to those diagnosed with CKDu in the previous 3 years. Of 320 eligible participants, 112 were classified as presumptive cases, 176 as controls and 32 as indeterminant. The risk of CKDu in those ever having worked in mining or construction was 4.4 times higher than in other participants (odds ratio = 4.44, 95% CI: 1.96-10.0, P = 0.0003). Eighty-three (26%) of the 320 participants were seropositive for at least one tested strain of Leptospira. No evidence of a causal link between leptospirosis or hantavirus and CKDu was found. The sensitivity analyses provide some evidence against the hypotheses that leptospirosis or hantavirus leads to CKDu within a few years. A major limitation was the impossibility of determining the absolute or relative timing of infection and CKDu onset. A prospective cohort design, with repeated collection of specimens over several years, could yield clearer answers about infections as potential etiologic agents in CKDu.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31309920 PMCID: PMC6726956 DOI: 10.4269/ajtmh.18-0856
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 2.345
Comparison of what Mesoamerican nephropathy (MeN) classifications of study participants would have been if purely creatinine-based criteria had been used (top row) and final classifications made by nephrologist using additional measurements and clinical judgment (bottom row), showing additions and subtractions
| Controls | Borderline, excluded | Cases | Creatinine values of participants whose categories changed (mg/dL) | |
|---|---|---|---|---|
| Using current creatinine value* | 178 | 29 | 113 | – |
| Changed from control to excluded | −2 | +2 | N.a. | 1.1 |
| Changed from excluded to case | N.a. | −2 | +2 | 1.3 (in women) |
| Changed from case to excluded | N.a. | +3 | −3 | 1.5 or 1.6 |
| Final† | 176 | 32 | 112 | – |
* Current creatinine ≤ 1.1 mg/dL = control, current creatinine > 1.1 and < 1.5 = excluded from main analysis, and current creatinine ≥ 1.5 mg/dL = case.
† A board-certified nephrologist with experience working in this population (D. J. F.) made the final designations of presumptive MeN case, control, and borderline/to-be-excluded based on information and measurements conducted on serum and urine samples obtained on the day of recruitment.
Characterization of study population by gender, age, and presumptive Mesoamerican nephropathy status
| Cases | Controls | Indeterminates | Total | |||||
|---|---|---|---|---|---|---|---|---|
| Number | Proportion (%) | Number | Proportion (%) | Number | Proportion (%) | Number | Proportion (%) | |
| Gender | ||||||||
| Male | 105 | 93.8 | 160 | 90.9 | 32 | 100.0 | 297 | 92.8 |
| Female | 7 | 6.2 | 16 | 9.1 | 0 | 0.0 | 23 | 7.2 |
| Age group | ||||||||
| 18–29 years | 4 | 3.6 | 28 | 15.9 | 4 | 12.5 | 36 | 11.3 |
| 30–39 years | 22 | 19.6 | 46 | 26.1 | 5 | 15.6 | 73 | 22.8 |
| 40–49 years | 34 | 30.4 | 44 | 25.0 | 10 | 31.3 | 88 | 27.5 |
| 50–59 years | 37 | 33.0 | 39 | 22.2 | 8 | 25.0 | 84 | 26.3 |
| 60–69 years | 15 | 13.4 | 17 | 9.7 | 5 | 15.6 | 37 | 11.6 |
| ≥ 70 years | 0 | 0.0 | 2 | 1.1 | 0 | 0.0 | 2 | 0.6 |
| Total | 112 | 100 | 176 | 100 | 32 | 100 | 320 | 100 |
Seropositivity to any strain of Leptospira, by demographic and occupational characteristics and MeN status
| Total | Number negative | Number positive | Proportion positive (%) | |
|---|---|---|---|---|
| Gender | ||||
| Male | 297 | 215 | 82 | 27.6 |
| Female | 23 | 22 | 1 | 4.3 |
| Age group | ||||
| 18–29 years | 36 | 28 | 8 | 22.2 |
| 30–39 years | 73 | 57 | 16 | 21.9 |
| 40–49 years | 88 | 61 | 27 | 30.7 |
| 50–59 years | 84 | 62 | 22 | 26.2 |
| 60–69 years | 37 | 27 | 10 | 27.0 |
| ≥ 70 years | 2 | 2 | 0 | 0.0 |
| Occupation (ever—categories not mutually exclusive) | ||||
| Mining | 191 | 148 | 43 | 22.5 |
| Masonry | 108 | 77 | 31 | 28.7 |
| Livestock-tending | 143 | 95 | 48 | 33.6 |
| Agriculture | 205 | 142 | 63 | 30.7 |
| Other | 115 | 90 | 25 | 21.7 |
| MeN status | ||||
| Case | 112 | 85 | 27 | 24.1 |
| Case diagnosed within previous 3 years | 50 | 35 | 15 | 30.0 |
| Control | 176 | 122 | 54 | 30.7 |
| Indeterminate, excluded | 32 | 30 | 2 | 6.2 |
| Total participants | 320 | 237 | 83 | 25.9 |
MeN = Mesoamerican nephropathy. Occupations refer to occupations ever engaged in and are not mutually exclusive.
Figure 1.Number of participants seropositive for Leptospira by number of serovars for which they were seropositive (n = 320).
Number of study participants seropositive for each Leptospira strain in the MAT conducted at the CDC by MeN status (n = 320)
| No. of MAT-positive participants | ||||
|---|---|---|---|---|
| Total | MeN cases | MeN controls | MeN indeterminate | |
| CDC standard panel (20 strains): | ||||
| | 0 | 0 | 0 | 0 |
| | 0 | 0 | 0 | 0 |
| | 6 | 3 | 3 | 0 |
| | 3 | 2 | 1 | 0 |
| | 0 | 0 | 0 | 0 |
| | 5 | 1 | 3 | 1 |
| | 11 | 5 | 6 | 0 |
| | 8 | 3 | 5 | 0 |
| | 3 | 0 | 3 | 0 |
| | 2 | 1 | 1 | 0 |
| | 1 | 0 | 1 | 0 |
| | 8 | 1 | 7 | 0 |
| | 4 | 3 | 1 | 0 |
| | 6 | 1 | 5 | 0 |
| | 3 | 0 | 3 | 0 |
| | 0 | 0 | 0 | 0 |
| | 7 | 1 | 5 | 1 |
| | 1 | 0 | 1 | 0 |
| | 7 | 1 | 6 | 0 |
| | 0 | 0 | 0 | 0 |
| Additional strains (4): | ||||
| | 3 | 0 | 3 | 0 |
| | 2 | 0 | 2 | 0 |
| | 57 | 20 | 36 | 1 |
| | 0 | 0 | 0 | 0 |
| Total positive MATs (in 83 of 320 participants) | 137 | 42 | 92 | 3 |
MAT = microscopic agglutination test; MeN = Mesoamerican nephropathy. Totals at bottom represent positive MATs, not unique individuals.